Family of 8-year-old with melanoma calls on all Australians to step up to help save lives

Family of 8-year-old with melanoma calls on all Australians to step up to help save lives

26 March 2021

Little Hayden Price was just 7-years-old when his parents noticed what they thought was an irritated skin tag on the back of his scalp. The adventurous school boy, who loves swimming and playing with his two older brothers Harry (10) and Hugh (11), began complaining that his goggles and hats were rubbing a sore spot on the back of his head.

His parents Liza and Nathan were shocked when a trip to the GP in Singapore, where they live as part of the Australian expat community, revealed the spot was in fact a melanoma.
Little Hayden underwent surgery to remove the melanoma early last July, just one day after his 8th birthday.

‘We just didn’t think that children as young as Hayden could get melanoma,’ said his mum Liza. ‘It just never crossed our minds that a cancer diagnosis was even possible. Hayden has never been sunburnt in his entire life so we were absolutely stunned and devastated.’

Melanoma Institute Australia (MIA) Co-Medical Director, Professor Richard Scolyer, who is the world’s leading melanoma pathologist, confirmed the difficult diagnosis. He said whilst melanoma is rare in young children, it does happen, and in Hayden’s case, his melanoma is a sub-type not related to sun exposure.

‘It is a dangerous misconception that melanoma is just an older person’s disease that occurs after decades of sun exposure,’ Professor Scolyer said. ‘Melanoma is in fact the most common cancer in 15 to 39 year old Australians, and whilst rare, we do also see a handful of cases each year in younger children.’

With Hayden’s melanoma already having spread to his lymph nodes, his case was referred to MIA Co-Medical Director and medical oncologist, Professor Georgina Long AO. Professor Long presented Hayden’s case at MIA’s weekly Multi-Disciplinary Team meeting where a cohort of leading clinicians brainstorm and discuss complex cases. A treatment plan was then agreed on with Hayden’s treating oncologist in Singapore.

‘Hayden was immediately started on immunotherapy, a breakthrough treatment which harnesses the body’s own immune system to fight the cancer cells,’ Professor Long said. ‘Had Hayden been born less than a decade earlier, this treatment would not have been available.’

Hayden has so far had 11 infusions of immunotherapy, and has six more to go. His family hopes he will be one of the lucky ones who responds to the treatment. They are anxiously awaiting results of follow up scans to see if the melanoma cells in his little body have been halted, slowed or killed.

‘We feel extremely fortunate that we have amazing specialists treating Hayden, combined with the availability of immunotherapy which was not available prior to 2017,’ Liza said. ‘This gives us tremendous hope for the future.’

The Price family, originally from Brisbane and Lismore, has decided to speak out and share their heartbreaking story to inspire Australians to rally and support research into new melanoma treatments, like the one they are confident will save Hayden’s life.

‘It was a difficult decision to go public with our story as we are in the middle of it, however we wanted to share this important message,’ Hayden’s dad Nathan said. ‘If you have doubts about changes in your child’s skin, including moles, bumps or lesions, please have them checked by a specialist, even in young kids.
‘Research into melanoma is changing lives for many families including ours, so please contribute by purchasing digital footprints supporting the Melanoma March campaign, if you can.’

MIA’s annual fundraising campaign, Melanoma March, is needing to raise $500,000 to support ongoing research focussing on the 50% of advanced melanoma patients who don’t respond to these new treatments. The traditional physical march events were unable to go ahead due to COVID, and were replaced with a digital campaign where people are asked to buy $30 digital footprints which they personalise with messages of hope or support. So far, $150,000 has been raised, leaving a further $350,000 to be raised to meet the target.

Australia has the highest melanoma rates in the world with one person diagnosed every 30 minutes. 1,300 Australians are expected to die from the disease this year.

‘Our story is proof that melanoma can and does impact anyone, regardless of age, and it is up to all of us to help support our research teams who are leading global efforts to save lives from this disease,’ Liza added.
‘That’s why we have decided to share our story, so that some good may possibly come from the difficult journey that Hayden and our family are now on.

To step up for Hayden and buy digital footprints, go to www.melanomamarch.org.au

 

Odd Sock Day  

Inspired by Hayden and his love of odd socks, the Australian International School in Singapore is holding an Odd Sock Day to raise funds for melanoma research. Australian schools and workplaces are urged to join them. All Odd Sock Day donations made at www.melanomamarch.org.au are converted into digital footprints to help us cover Australia.

 

Hayden's Story on 9News 

 

Melanoma March is an initiative of Melanoma Institute Australia, incorporating melanomaWA and Amie St Clair. It is proudly supported by Melanoma Patients Australia, Australian Melanoma Research Foundation, Skin Cancer Tasmania and other melanoma research organisations across Australia.

 

MEDIA - For more information, please contact:
Jennifer Durante |Melanoma Institute Australia | 0412 798 990 | jennifer.durante@melanoma.org.au

Australia at risk of falling behind USA and Europe in preventing deadly recurrence of Melanoma
23 Aug 2019

Australia at risk of falling behind USA and Europe in preventing deadly recurrence of Melanoma

Federal government urged to provide certainty of access to immunotherapy for high risk melanoma patients.

Team Melanoma smashes City2Surf
16 Aug 2019

Team Melanoma smashes City2Surf

We want to thank every member of Team Melanoma and everyone who donated to them. With your help, we are moving closer to our goal of zero deaths from melanoma!

Ready to run over melanoma at City2Surf 2019
08 Aug 2019

Ready to run over melanoma at City2Surf 2019

Lauren O'Brien tells us why she's running for a cause close to her heart

Community Fundraising July Wrap-Up
01 Aug 2019

Community Fundraising July Wrap-Up

MIA could not do what we do without the incredible support and effort of our community fundraisers. We’d like to highlight some of the wonderful events organised by our community in the month of July that are helping us move closer to our goal of zero deaths from melanoma.

Breast cancer drug may hold key to tackling most deadly type of melanoma
23 Jul 2019

Breast cancer drug may hold key to tackling most deadly type of melanoma

An international study, led by researchers from Melanoma Institute Australia, QIMR Berghofer Medical Research Institute and The University of Sydney as part of the Australian Melanoma Genome Project, has discovered that a drug traditionally used to treat a type of breast cancer may hold the key to treating an aggressive and deadly form of melanoma.

MIA takes centre stage at leading cancer conference
05 Jun 2019

MIA takes centre stage at leading cancer conference

Researchers from Melanoma Institute Australia took centre stage at the American Society of Clinical Oncology Annual Meeting in Chicago. Results presented by MIA’s contingent have the potential to create better patient outcomes and change the way advanced melanoma is treated .

International Clinical Trials Day 2019
20 May 2019

International Clinical Trials Day 2019

Today is International Clinical Trials Day – a day to recognise and thank the amazing people who conduct, organise, and coordinate clinical trials.

Emma Betts' legacy will live on
17 May 2019

Emma Betts' legacy will live on

“I’m the age Emma was when she passed away. It almost feels unfair, that she has to not be here for me to be able to do this. But I will use this opportunity to push as hard as I can to reach our collective goal of zero deaths from melanoma.”

Support PBS listing for three adjuvant treatments of resected Stage III melanoma
13 May 2019

Support PBS listing for three adjuvant treatments of resected Stage III melanoma

As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.

Support PBS listing for pembrolizumab
06 May 2019

Support PBS listing for pembrolizumab

As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.

How are the Premier's Awards helping cancer researchers?
02 May 2019

How are the Premier's Awards helping cancer researchers?

MIA had four winners in the 2017 Premiers Awards. Find out how winning has influenced their work over the past year.

Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects
19 Mar 2019

Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects

Almost $9 million of new funding was awarded to 13 ground-breaking cancer research projects at the 2019 Cancer Council NSW Research Awards.

Making a difference to many
15 Mar 2019

Making a difference to many

Georgina V. Long is co-medical director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research. She is the first woman president of the Society for Melanoma Research.

Aussie icon Sophie Monk calls on Australians to get behind Melanoma March
26 Feb 2019

Aussie icon Sophie Monk calls on Australians to get behind Melanoma March

Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.

Melanoma breakthrough paves way for personalised treatment for all cancer patients
14 Feb 2019

Melanoma breakthrough paves way for personalised treatment for all cancer patients

Australian researchers have for the first time identified specific cells and receptors in the immune system which predict how a patient will respond to treatment with immunotherapies, potentially paving the way for the development of personalised therapy for all cancer patients.

Melanoma March announces 2019 Principal Partner
07 Feb 2019

Melanoma March announces 2019 Principal Partner

Melanoma March is thrilled to introduce Ricky as our official Principal Partner for 2019!

Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma
05 Feb 2019

Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma

World record holder, Olympian and Australian swimming champion Cate Campbell has been announced as National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.

MIA experts collaborate on groundbreaking research
16 Jan 2019

MIA experts collaborate on groundbreaking research

MIA's expertise was essential to a recent Nature publication spearheaded by Perth’s Telethon Kids Institute and The University of Melbourne.

World-leading pathologist Associate Professor Michael Tetzlaff visits MIA
20 Dec 2018

World-leading pathologist Associate Professor Michael Tetzlaff visits MIA

MIA is delighted to be hosting the MD Anderson pathologist on his first ever trip to Australia.

Possible PBS listing for dabrafenib and trametinib
18 Dec 2018

Possible PBS listing for dabrafenib and trametinib

Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for dabrafenib and trametinib.